메뉴 건너뛰기




Volumn 24, Issue 10, 2010, Pages 1671-1674

What is the "true" incidence of active surveillance and brachytherapy candidates in men undergoing robot-assisted radical prostatectomy?

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 77957987818     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.0644     Document Type: Article
Times cited : (3)

References (28)
  • 1
    • 0033575051 scopus 로고    scopus 로고
    • Cancer surveillance series: Interpreting trends in prostate cancer-Part I: Evidence of the effects in screening in recent prostate cancer incidence, mortality, and survival rates
    • Hankey BF, Fuer EJ, Clegg LX, et al. Cancer surveillance series: Interpreting trends in prostate cancer-Part I: Evidence of the effects in screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999;91:1017-1024.
    • (1999) J. Natl. Cancer Inst. , vol.91 , pp. 1017-1024
    • Hankey, B.F.1    Fuer, E.J.2    Clegg, L.X.3
  • 2
    • 0030686591 scopus 로고    scopus 로고
    • The results of prostate carcinoma screening in the U. S. as reflected in the surveillance, epidemiology, and end results program
    • Smart CR. The results of prostate carcinoma screening in the U. S. as reflected in the surveillance, epidemiology, and end results program. Cancer 1997;80:1835-1844.
    • (1997) Cancer , vol.80 , pp. 1835-1844
    • Smart, C.R.1
  • 3
    • 0034940986 scopus 로고    scopus 로고
    • Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer
    • Han M, Partin A, Piantadosi S, et al. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol 2001;166:416-419.
    • (2001) J. Urol. , vol.166 , pp. 416-419
    • Han, M.1    Partin, A.2    Piantadosi, S.3
  • 4
    • 0037263950 scopus 로고    scopus 로고
    • Watchful waiting as a treatment option for localized prostate cancer in the PSA era
    • Kakehi Y. Watchful waiting as a treatment option for localized prostate cancer in the PSA era. Jpn J Clin Oncol 2003;33:1-5.
    • (2003) Jpn. J. Clin. Oncol. , vol.33 , pp. 1-5
    • Kakehi, Y.1
  • 5
    • 0037304517 scopus 로고    scopus 로고
    • Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
    • Han M, Partin AW, Zahurak M, et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003;169:517-523.
    • (2003) J. Urol. , vol.169 , pp. 517-523
    • Han, M.1    Partin, A.W.2    Zahurak, M.3
  • 6
    • 36549047063 scopus 로고    scopus 로고
    • Contemporary evaluation of the D'amico risk classification of prostate cancer
    • Hernandez DJ, Nielsen ME, Han M, Partin AW. Contemporary evaluation of the D'amico risk classification of prostate cancer. Urology 2007;70:931-935.
    • (2007) Urology , vol.70 , pp. 931-935
    • Hernandez, D.J.1    Nielsen, M.E.2    Han, M.3    Partin, A.W.4
  • 7
    • 0032550753 scopus 로고    scopus 로고
    • A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
    • Kattan MW, Eastham JA, Stapleton AM, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998;90:766-771.
    • (1998) J. Natl. Cancer Inst. , vol.90 , pp. 766-771
    • Kattan, M.W.1    Eastham, J.A.2    Stapleton, A.M.3
  • 8
    • 33646945083 scopus 로고    scopus 로고
    • Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    • Stephenson AJ, Scardino PT, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 2006;98:715-717.
    • (2006) J. Natl. Cancer Inst. , vol.98 , pp. 715-717
    • Stephenson, A.J.1    Scardino, P.T.2    Eastham, J.A.3
  • 9
    • 0033992281 scopus 로고    scopus 로고
    • The percent of cores positive for cancer in prostate needle specimens is strongly predictive of tumor stage and volume at radical prostatectomy
    • Sebo TJ, Bock BJ, Cheville JC, et al. The percent of cores positive for cancer in prostate needle specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol 2000;163:174-178.
    • (2000) J. Urol. , vol.163 , pp. 174-178
    • Sebo, T.J.1    Bock, B.J.2    Cheville, J.C.3
  • 11
    • 0038626279 scopus 로고    scopus 로고
    • Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: Results from the SEARCH Database
    • Freedland SJ, Aronson WJ, Terris MK, et al. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: Results from the SEARCH Database. J Urol 2003;169:2136-2141.
    • (2003) J. Urol. , vol.169 , pp. 2136-2141
    • Freedland, S.J.1    Aronson, W.J.2    Terris, M.K.3
  • 12
    • 84942475860 scopus 로고
    • Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
    • Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994;271:368-374.
    • (1994) JAMA , vol.271 , pp. 368-374
    • Epstein, J.I.1    Walsh, P.C.2    Carmichael, M.3    Brendler, C.B.4
  • 13
    • 0036130518 scopus 로고    scopus 로고
    • Feasibility study: Watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression
    • Choo R, Klotz L, Danjoux C, et al. Feasibility study: Watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 2002;167:1664-1669.
    • (2002) J. Urol. , vol.167 , pp. 1664-1669
    • Choo, R.1    Klotz, L.2    Danjoux, C.3
  • 14
    • 0033047030 scopus 로고    scopus 로고
    • American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer
    • Nag S, Beyer D, Friedland J, et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999;44:789-799.
    • (1999) Int. J. Radiat Oncol. Biol. Phys. , vol.44 , pp. 789-799
    • Nag, S.1    Beyer, D.2    Friedland, J.3
  • 15
    • 0141919742 scopus 로고    scopus 로고
    • Counseling men with prostate cancer: A nomogram for predicting the presence of small, moderately differentiated, confined tumors
    • Kattan MW, Eastham JA, Wheeler TM, et al. Counseling men with prostate cancer: A nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 2003;170:1792-1797.
    • (2003) J. Urol. , vol.170 , pp. 1792-1797
    • Kattan, M.W.1    Eastham, J.A.2    Wheeler, T.M.3
  • 16
    • 63249122661 scopus 로고    scopus 로고
    • Mortality results from a randomized prostate-cancer screening trial
    • Andriole GL, Crawford ED, Grubb RL III, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360:1310-1319.
    • (2009) N Engl. J. Med. , vol.360 , pp. 1310-1319
    • Andriole, G.L.1    Crawford, E.D.2    Grubb III, R.L.3
  • 17
    • 63249118690 scopus 로고    scopus 로고
    • Screening and prostate-cancer mortality in a randomized European study
    • Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-1328.
    • (2009) N Engl. J. Med. , vol.360 , pp. 1320-1328
    • Schröder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 18
    • 0028158141 scopus 로고
    • Results of conservative management of clinically localized prostate cancer
    • Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994;330:242-248.
    • (1994) N Engl. J. Med. , vol.330 , pp. 242-248
    • Chodak, G.W.1    Thisted, R.A.2    Gerber, G.S.3
  • 19
    • 0029081776 scopus 로고
    • Long-term survival among men with conservatively treated localized prostate cancer
    • Albertsen PC, Fryback DG, Storer BE, et al. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995;274:626-631.
    • (1995) JAMA , vol.274 , pp. 626-631
    • Albertsen, P.C.1    Fryback, D.G.2    Storer, B.E.3
  • 20
    • 62049086309 scopus 로고    scopus 로고
    • A multi-institutional evaluation of active surveillance for low risk prostate cancer
    • Eggener SE, Mueller A, Berglund RK, et al. A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol 2009;181:1635-1641.
    • (2009) J. Urol. , vol.181 , pp. 1635-1641
    • Eggener, S.E.1    Mueller, A.2    Berglund, R.K.3
  • 21
    • 0032461041 scopus 로고    scopus 로고
    • An analysis of watchful waiting for clinically localized prostate cancer
    • Steinberg GD, Bales GT, Brendler CB. An analysis of watchful waiting for clinically localized prostate cancer. J Urol 1998;159:1431-1436.
    • (1998) J. Urol. , vol.159 , pp. 1431-1436
    • Steinberg, G.D.1    Bales, G.T.2    Brendler, C.B.3
  • 22
    • 0036160557 scopus 로고    scopus 로고
    • Expectant management of nonpalpable prostate cancer with curative intent: Preliminary results
    • Carter HB, Walsh PC, Landis P, Epstein JI. Expectant management of nonpalpable prostate cancer with curative intent: Preliminary results. J Urol 2002;167:1231-1234.
    • (2002) J. Urol. , vol.167 , pp. 1231-1234
    • Carter, H.B.1    Walsh, P.C.2    Landis, P.3    Epstein, J.I.4
  • 23
    • 0642342662 scopus 로고    scopus 로고
    • Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostatespecific antigen era
    • Carter CA, Donahue T, Sun L, et al. Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostatespecific antigen era. J Clin Oncol 2003;21:4001-4008.
    • (2003) J. Clin. Oncol. , vol.21 , pp. 4001-4008
    • Carter, C.A.1    Donahue, T.2    Sun, L.3
  • 24
    • 0242570966 scopus 로고    scopus 로고
    • Quality of life issues in patients with prostate cancer
    • Houston, TX: AUA Office of Education
    • Penson D, Litwin M. Quality of life issues in patients with prostate cancer. AUA Update Series, vol. 20. Houston, TX: AUA Office of Education, 2001, pp 18-24.
    • (2001) AUA Update Series , vol.20 , pp. 18-24
    • Penson, D.1    Litwin, M.2
  • 25
    • 0037068646 scopus 로고    scopus 로고
    • A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer
    • Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347:781-789.
    • (2002) N Engl. J. Med. , vol.347 , pp. 781-789
    • Holmberg, L.1    Bill-Axelson, A.2    Helgesen, F.3
  • 27
    • 50949094086 scopus 로고    scopus 로고
    • Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era
    • Ercole B, Marietti SR, Fine J, Albertsen PC. Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era. J Urol 2008;180:1336-1341.
    • (2008) J. Urol. , vol.180 , pp. 1336-1341
    • Ercole, B.1    Marietti, S.R.2    Fine, J.3    Albertsen, P.C.4
  • 28
    • 34249987954 scopus 로고    scopus 로고
    • Cost-benefit and outcome analysis: Effect of prostate biopsy undergrading
    • Cambio AJ, Ellison LM, Chamie K, et al. Cost-benefit and outcome analysis: Effect of prostate biopsy undergrading. Urology 2007;69:1152-1156.
    • (2007) Urology , vol.69 , pp. 1152-1156
    • Cambio, A.J.1    Ellison, L.M.2    Chamie, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.